Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 18:11:37 GMT 2023
by
admin
on
Sat Dec 16 18:11:37 GMT 2023
|
Protein Type | ENZYME |
Protein Sub Type | TYROSINE KINASE |
Sequence Origin | HUMAN |
Sequence Type | COMPLETE |
Record UNII |
N3H2YMZ2NH
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
N3H2YMZ2NH
Created by
admin on Sat Dec 16 18:11:38 GMT 2023 , Edited by admin on Sat Dec 16 18:11:38 GMT 2023
|
PRIMARY |
From | To |
---|---|
1_109 | 1_114 |
Glycosylation Type | HUMAN |
Glycosylation Link Type | Site |
---|---|
N | 1_70 |
N | 1_123 |
N | 1_171 |
N | 1_308 |
N | 1_315 |
N | 1_333 |
N | 1_339 |
N | 1_349 |
N | 1_366 |
N | 1_420 |
N | 1_440 |
N | 1_526 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
INHIBITOR RESISTANT -> TARGET |
IC50
|
||
|
TARGET -> INHIBITOR |
IC50
|
||
|
INHIBITOR RESISTANT -> TARGET |
IC50
|
||
|
TARGET -> INHIBITOR |
Selpercatinib was found to be 60−1300-fold more effective than other MKIs against cell lines engineered with KIF5BRETV804L/M gatekeeper mutations.
IC50
|
||
|
INHIBITOR RESISTANT -> TARGET |
IC50
|